 Allison Kempe
Concepts (546)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 76 | 2025 | 1381 | 14.700 |
Why?
| | Influenza Vaccines | 37 | 2021 | 539 | 9.430 |
Why?
| | Reminder Systems | 26 | 2021 | 169 | 8.580 |
Why?
| | Immunization Programs | 32 | 2021 | 213 | 8.480 |
Why?
| | Attitude of Health Personnel | 42 | 2025 | 1171 | 7.910 |
Why?
| | Papillomavirus Vaccines | 22 | 2025 | 238 | 7.670 |
Why?
| | Influenza, Human | 28 | 2021 | 622 | 7.400 |
Why?
| | Practice Patterns, Physicians' | 39 | 2021 | 1313 | 6.610 |
Why?
| | Immunization | 27 | 2021 | 411 | 6.390 |
Why?
| | Physicians, Primary Care | 15 | 2021 | 236 | 5.890 |
Why?
| | Parents | 37 | 2025 | 1347 | 5.870 |
Why?
| | Pediatrics | 42 | 2025 | 1101 | 5.610 |
Why?
| | Vaccines | 24 | 2021 | 406 | 5.310 |
Why?
| | Health Knowledge, Attitudes, Practice | 28 | 2021 | 1329 | 5.120 |
Why?
| | Papillomavirus Infections | 16 | 2025 | 325 | 5.000 |
Why?
| | Pediatricians | 10 | 2024 | 129 | 4.350 |
Why?
| | Physicians, Family | 14 | 2021 | 201 | 3.830 |
Why?
| | Attitude to Health | 12 | 2020 | 439 | 3.510 |
Why?
| | School Health Services | 15 | 2018 | 238 | 3.460 |
Why?
| | Patient Acceptance of Health Care | 20 | 2025 | 806 | 3.320 |
Why?
| | Primary Health Care | 27 | 2023 | 1738 | 3.190 |
Why?
| | Immunization Schedule | 15 | 2021 | 197 | 2.920 |
Why?
| | Vaccination Refusal | 6 | 2021 | 70 | 2.770 |
Why?
| | Pneumococcal Vaccines | 9 | 2021 | 142 | 2.710 |
Why?
| | Health Care Surveys | 26 | 2021 | 565 | 2.700 |
Why?
| | Child | 115 | 2025 | 21935 | 2.670 |
Why?
| | Colorado | 63 | 2025 | 4565 | 2.560 |
Why?
| | Infant | 77 | 2025 | 9465 | 2.470 |
Why?
| | Family Practice | 17 | 2018 | 464 | 2.310 |
Why?
| | Insurance, Health, Reimbursement | 6 | 2018 | 99 | 2.280 |
Why?
| | Physicians | 15 | 2022 | 910 | 2.270 |
Why?
| | Humans | 232 | 2025 | 137585 | 2.250 |
Why?
| | Adolescent | 85 | 2025 | 21513 | 2.060 |
Why?
| | United States | 71 | 2021 | 14841 | 2.030 |
Why?
| | Child, Preschool | 65 | 2025 | 11074 | 2.020 |
Why?
| | Surveys and Questionnaires | 37 | 2025 | 5778 | 2.010 |
Why?
| | Herpes Zoster Vaccine | 7 | 2022 | 159 | 2.010 |
Why?
| | Female | 144 | 2025 | 73304 | 2.010 |
Why?
| | Male | 137 | 2025 | 67762 | 1.980 |
Why?
| | Shock, Septic | 3 | 2025 | 219 | 1.920 |
Why?
| | Rotavirus Vaccines | 5 | 2021 | 46 | 1.770 |
Why?
| | Child Health Services | 10 | 2015 | 184 | 1.720 |
Why?
| | Sepsis | 7 | 2023 | 617 | 1.720 |
Why?
| | Vaccination Coverage | 4 | 2021 | 82 | 1.720 |
Why?
| | Meningococcal Vaccines | 5 | 2018 | 55 | 1.670 |
Why?
| | Emergency Service, Hospital | 14 | 2025 | 2069 | 1.550 |
Why?
| | Rotavirus Infections | 4 | 2021 | 43 | 1.480 |
Why?
| | Text Messaging | 6 | 2021 | 157 | 1.470 |
Why?
| | Mumps | 2 | 2022 | 25 | 1.460 |
Why?
| | Medicaid | 6 | 2021 | 435 | 1.420 |
Why?
| | Ureteral Obstruction | 4 | 2021 | 64 | 1.410 |
Why?
| | Herpes Zoster | 4 | 2022 | 316 | 1.370 |
Why?
| | Triage | 8 | 2007 | 222 | 1.300 |
Why?
| | Nervous System Diseases | 4 | 2021 | 266 | 1.280 |
Why?
| | Adult | 59 | 2025 | 37929 | 1.280 |
Why?
| | Organ Transplantation | 4 | 2023 | 250 | 1.280 |
Why?
| | Fundoplication | 3 | 2016 | 53 | 1.250 |
Why?
| | Gastrostomy | 3 | 2016 | 117 | 1.240 |
Why?
| | Health Care Costs | 4 | 2017 | 398 | 1.220 |
Why?
| | Adolescent Health Services | 3 | 2015 | 71 | 1.170 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 6 | 2019 | 91 | 1.150 |
Why?
| | Treatment Refusal | 4 | 2018 | 89 | 1.140 |
Why?
| | Gynecology | 3 | 2019 | 168 | 1.110 |
Why?
| | Data Collection | 17 | 2020 | 673 | 1.100 |
Why?
| | Middle Aged | 45 | 2021 | 33479 | 1.090 |
Why?
| | Guideline Adherence | 8 | 2020 | 556 | 1.070 |
Why?
| | Patient-Centered Care | 7 | 2023 | 530 | 1.060 |
Why?
| | Urban Population | 7 | 2019 | 479 | 1.060 |
Why?
| | Patient Readmission | 3 | 2019 | 697 | 1.050 |
Why?
| | Insurance, Health | 6 | 2016 | 283 | 1.040 |
Why?
| | Chronic Disease | 8 | 2021 | 1793 | 1.040 |
Why?
| | Practice Guidelines as Topic | 14 | 2021 | 1587 | 1.020 |
Why?
| | Internal Medicine | 5 | 2014 | 265 | 1.010 |
Why?
| | Respiratory Syncytial Virus Infections | 2 | 2018 | 128 | 1.010 |
Why?
| | State Health Plans | 5 | 2005 | 30 | 1.000 |
Why?
| | Rural Population | 7 | 2019 | 563 | 0.990 |
Why?
| | Research Design | 4 | 2023 | 1139 | 0.980 |
Why?
| | Professional-Family Relations | 3 | 2016 | 143 | 0.980 |
Why?
| | Clinical Competence | 4 | 2018 | 1118 | 0.980 |
Why?
| | Delivery of Health Care | 7 | 2022 | 951 | 0.960 |
Why?
| | Meningococcal Infections | 2 | 2018 | 25 | 0.950 |
Why?
| | Telephone | 8 | 2010 | 173 | 0.940 |
Why?
| | Health Services Research | 5 | 2018 | 404 | 0.900 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2020 | 394 | 0.890 |
Why?
| | Qualitative Research | 8 | 2025 | 1386 | 0.890 |
Why?
| | Mobile Applications | 2 | 2025 | 183 | 0.870 |
Why?
| | Quality of Health Care | 3 | 2023 | 642 | 0.870 |
Why?
| | Physician-Patient Relations | 3 | 2019 | 548 | 0.870 |
Why?
| | Kidney Pelvis | 2 | 2021 | 24 | 0.860 |
Why?
| | Pneumococcal Infections | 3 | 2018 | 115 | 0.860 |
Why?
| | Measles | 2 | 2022 | 46 | 0.850 |
Why?
| | Polypharmacy | 3 | 2025 | 85 | 0.850 |
Why?
| | Preventive Health Services | 2 | 2016 | 148 | 0.850 |
Why?
| | Decision Support Systems, Clinical | 2 | 2025 | 226 | 0.840 |
Why?
| | Medication Therapy Management | 2 | 2023 | 76 | 0.830 |
Why?
| | Hotlines | 4 | 2005 | 32 | 0.820 |
Why?
| | General Practitioners | 2 | 2021 | 28 | 0.820 |
Why?
| | Hospitals, Pediatric | 9 | 2024 | 508 | 0.800 |
Why?
| | Immunocompromised Host | 3 | 2019 | 202 | 0.800 |
Why?
| | New York | 5 | 2020 | 126 | 0.780 |
Why?
| | Vaccines, Synthetic | 2 | 2022 | 126 | 0.760 |
Why?
| | Gastroesophageal Reflux | 2 | 2016 | 234 | 0.760 |
Why?
| | Information Dissemination | 2 | 2015 | 218 | 0.760 |
Why?
| | Liver Transplantation | 3 | 2019 | 871 | 0.750 |
Why?
| | Rubella | 1 | 2022 | 24 | 0.750 |
Why?
| | Decision Making | 7 | 2019 | 900 | 0.750 |
Why?
| | Retrospective Studies | 28 | 2024 | 15657 | 0.750 |
Why?
| | Hospitalization | 6 | 2019 | 2199 | 0.740 |
Why?
| | Neisseria meningitidis, Serogroup B | 2 | 2018 | 16 | 0.740 |
Why?
| | Medically Uninsured | 7 | 2014 | 130 | 0.740 |
Why?
| | Hepatitis B Vaccines | 4 | 2010 | 45 | 0.740 |
Why?
| | Health Services Accessibility | 8 | 2019 | 986 | 0.740 |
Why?
| | Urologic Surgical Procedures | 3 | 2021 | 120 | 0.730 |
Why?
| | Advisory Committees | 4 | 2021 | 219 | 0.730 |
Why?
| | Insurance Coverage | 5 | 2018 | 230 | 0.720 |
Why?
| | Infant, Newborn | 19 | 2021 | 6079 | 0.720 |
Why?
| | Community Health Centers | 3 | 2018 | 60 | 0.710 |
Why?
| | Poverty | 8 | 2018 | 521 | 0.710 |
Why?
| | Cost-Benefit Analysis | 8 | 2019 | 591 | 0.710 |
Why?
| | Algorithms | 4 | 2019 | 1704 | 0.710 |
Why?
| | Prescription Drug Overuse | 1 | 2020 | 13 | 0.690 |
Why?
| | Refusal to Treat | 1 | 2020 | 17 | 0.680 |
Why?
| | Motivation | 3 | 2023 | 570 | 0.680 |
Why?
| | Standing Orders | 1 | 2020 | 11 | 0.670 |
Why?
| | Models, Statistical | 1 | 2024 | 669 | 0.660 |
Why?
| | Patient Participation | 3 | 2012 | 420 | 0.660 |
Why?
| | Patient Admission | 2 | 2019 | 197 | 0.650 |
Why?
| | Reimbursement Mechanisms | 3 | 2018 | 85 | 0.650 |
Why?
| | Computer Simulation | 1 | 2024 | 978 | 0.650 |
Why?
| | Hydronephrosis | 2 | 2021 | 36 | 0.640 |
Why?
| | Emergencies | 3 | 2007 | 164 | 0.640 |
Why?
| | Symptom Assessment | 1 | 2020 | 128 | 0.640 |
Why?
| | Opportunistic Infections | 1 | 2019 | 46 | 0.620 |
Why?
| | Quality Improvement | 5 | 2020 | 1178 | 0.620 |
Why?
| | Policy | 1 | 2020 | 150 | 0.620 |
Why?
| | Obstetrics | 2 | 2019 | 163 | 0.620 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2016 | 103 | 0.610 |
Why?
| | Consumer Behavior | 4 | 2014 | 71 | 0.600 |
Why?
| | Patient Compliance | 5 | 2016 | 581 | 0.600 |
Why?
| | Age Factors | 8 | 2021 | 3295 | 0.600 |
Why?
| | Analgesics | 1 | 2020 | 206 | 0.600 |
Why?
| | Public Health Practice | 2 | 2012 | 70 | 0.590 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2020 | 148 | 0.590 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2018 | 36 | 0.590 |
Why?
| | Public-Private Sector Partnerships | 2 | 2019 | 43 | 0.580 |
Why?
| | Hospital Costs | 1 | 2019 | 117 | 0.580 |
Why?
| | Hospitals | 2 | 2021 | 691 | 0.570 |
Why?
| | Risk Assessment | 5 | 2019 | 3457 | 0.570 |
Why?
| | Registries | 9 | 2019 | 2035 | 0.560 |
Why?
| | Vaccines, Conjugate | 3 | 2018 | 65 | 0.560 |
Why?
| | Professional Practice | 1 | 2018 | 64 | 0.550 |
Why?
| | Cooperative Behavior | 3 | 2015 | 451 | 0.530 |
Why?
| | Pandemics | 3 | 2021 | 1639 | 0.530 |
Why?
| | Tertiary Care Centers | 1 | 2018 | 160 | 0.530 |
Why?
| | Pragmatic Clinical Trials as Topic | 2 | 2015 | 65 | 0.530 |
Why?
| | Multivariate Analysis | 9 | 2020 | 1509 | 0.530 |
Why?
| | Hepatitis A | 1 | 2017 | 26 | 0.530 |
Why?
| | Clinical Decision-Making | 4 | 2021 | 322 | 0.530 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 402 | 0.520 |
Why?
| | Diagnostic Errors | 1 | 2018 | 170 | 0.520 |
Why?
| | Health Promotion | 2 | 2015 | 741 | 0.520 |
Why?
| | Physician's Role | 2 | 2019 | 211 | 0.510 |
Why?
| | Information Systems | 1 | 2016 | 61 | 0.510 |
Why?
| | Public Health | 3 | 2017 | 588 | 0.510 |
Why?
| | Gastrointestinal Agents | 1 | 2016 | 65 | 0.500 |
Why?
| | Cross Infection | 1 | 2019 | 256 | 0.500 |
Why?
| | Quality Assurance, Health Care | 4 | 2008 | 322 | 0.500 |
Why?
| | Regression Analysis | 6 | 2020 | 1024 | 0.490 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 232 | 0.490 |
Why?
| | Transplant Recipients | 1 | 2018 | 184 | 0.490 |
Why?
| | Young Adult | 17 | 2020 | 13209 | 0.490 |
Why?
| | Directive Counseling | 1 | 2016 | 47 | 0.490 |
Why?
| | Health Information Systems | 1 | 2015 | 17 | 0.480 |
Why?
| | Local Government | 1 | 2015 | 28 | 0.480 |
Why?
| | After-Hours Care | 2 | 2006 | 15 | 0.470 |
Why?
| | Universities | 2 | 2015 | 433 | 0.470 |
Why?
| | Cross-Sectional Studies | 13 | 2022 | 5472 | 0.460 |
Why?
| | Parental Consent | 2 | 2014 | 25 | 0.460 |
Why?
| | Postnatal Care | 1 | 2015 | 71 | 0.460 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2015 | 250 | 0.450 |
Why?
| | Spinal Fusion | 3 | 2013 | 251 | 0.450 |
Why?
| | Communicable Diseases | 1 | 2017 | 159 | 0.450 |
Why?
| | Community Health Services | 5 | 2018 | 227 | 0.440 |
Why?
| | Private Practice | 2 | 2012 | 25 | 0.440 |
Why?
| | Immunosuppressive Agents | 1 | 2019 | 890 | 0.440 |
Why?
| | Intubation, Gastrointestinal | 1 | 2014 | 79 | 0.430 |
Why?
| | Ambulatory Care | 2 | 2015 | 546 | 0.430 |
Why?
| | Cohort Studies | 13 | 2019 | 5742 | 0.430 |
Why?
| | Breast Feeding | 2 | 2010 | 440 | 0.430 |
Why?
| | Documentation | 1 | 2015 | 194 | 0.420 |
Why?
| | Public Health Administration | 1 | 2014 | 76 | 0.420 |
Why?
| | California | 2 | 2025 | 431 | 0.410 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 179 | 0.410 |
Why?
| | Referral and Consultation | 6 | 2014 | 786 | 0.410 |
Why?
| | Medical Assistance | 2 | 2004 | 12 | 0.400 |
Why?
| | Safety | 2 | 2013 | 338 | 0.400 |
Why?
| | Prescription Drugs | 1 | 2014 | 109 | 0.390 |
Why?
| | Focus Groups | 5 | 2017 | 522 | 0.390 |
Why?
| | Enteral Nutrition | 1 | 2014 | 202 | 0.390 |
Why?
| | Disease Outbreaks | 3 | 2022 | 395 | 0.390 |
Why?
| | Seasons | 5 | 2020 | 547 | 0.380 |
Why?
| | Feasibility Studies | 3 | 2025 | 956 | 0.380 |
Why?
| | Electronic Mail | 3 | 2018 | 64 | 0.380 |
Why?
| | Neisseria meningitidis | 1 | 2011 | 23 | 0.370 |
Why?
| | Pediatric Nursing | 2 | 2005 | 42 | 0.370 |
Why?
| | Nurses | 4 | 2018 | 180 | 0.360 |
Why?
| | Interviews as Topic | 4 | 2024 | 786 | 0.360 |
Why?
| | Postoperative Complications | 4 | 2018 | 2654 | 0.360 |
Why?
| | Risk Factors | 10 | 2019 | 10388 | 0.360 |
Why?
| | Community-Acquired Infections | 2 | 2024 | 174 | 0.360 |
Why?
| | Awards and Prizes | 2 | 2012 | 67 | 0.360 |
Why?
| | Asthma | 7 | 2023 | 2295 | 0.360 |
Why?
| | Outpatients | 1 | 2015 | 396 | 0.360 |
Why?
| | Time Factors | 12 | 2015 | 6828 | 0.360 |
Why?
| | Syncope | 1 | 2011 | 52 | 0.350 |
Why?
| | Costs and Cost Analysis | 4 | 2018 | 213 | 0.350 |
Why?
| | Lactic Acid | 3 | 2017 | 305 | 0.350 |
Why?
| | Laparotomy | 1 | 2011 | 109 | 0.340 |
Why?
| | Drug Recalls | 1 | 2010 | 5 | 0.340 |
Why?
| | Albuterol | 1 | 2011 | 110 | 0.340 |
Why?
| | Licensure, Medical | 1 | 2010 | 20 | 0.340 |
Why?
| | Aged | 12 | 2021 | 23961 | 0.340 |
Why?
| | Medical Records Systems, Computerized | 1 | 2011 | 96 | 0.330 |
Why?
| | General Surgery | 1 | 2012 | 173 | 0.330 |
Why?
| | Haemophilus Vaccines | 1 | 2010 | 30 | 0.330 |
Why?
| | Medicare Part D | 1 | 2010 | 25 | 0.330 |
Why?
| | Health Surveys | 4 | 2018 | 514 | 0.330 |
Why?
| | Polysaccharides, Bacterial | 1 | 2010 | 70 | 0.320 |
Why?
| | Haemophilus Infections | 1 | 2010 | 42 | 0.320 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2010 | 58 | 0.320 |
Why?
| | Haemophilus influenzae | 1 | 2010 | 63 | 0.320 |
Why?
| | Severity of Illness Index | 5 | 2020 | 2828 | 0.320 |
Why?
| | Incidence | 4 | 2019 | 2804 | 0.320 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1477 | 0.310 |
Why?
| | Health Policy | 3 | 2017 | 388 | 0.310 |
Why?
| | Parent-Child Relations | 2 | 2015 | 272 | 0.310 |
Why?
| | Bronchodilator Agents | 1 | 2011 | 252 | 0.310 |
Why?
| | Patient Education as Topic | 2 | 2011 | 766 | 0.310 |
Why?
| | Communication | 4 | 2021 | 879 | 0.300 |
Why?
| | Hepatitis B | 1 | 2009 | 70 | 0.290 |
Why?
| | Health Services Needs and Demand | 2 | 2007 | 273 | 0.290 |
Why?
| | Pregnancy | 5 | 2020 | 6763 | 0.290 |
Why?
| | North Carolina | 2 | 2019 | 110 | 0.280 |
Why?
| | Neuralgia, Postherpetic | 1 | 2008 | 40 | 0.280 |
Why?
| | Sentinel Surveillance | 1 | 2008 | 49 | 0.280 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 307 | 0.280 |
Why?
| | Pneumonia | 2 | 2024 | 639 | 0.280 |
Why?
| | Immunization, Secondary | 3 | 2018 | 87 | 0.280 |
Why?
| | Kidney | 1 | 2015 | 1468 | 0.270 |
Why?
| | Anti-Bacterial Agents | 4 | 2025 | 1809 | 0.270 |
Why?
| | Postal Service | 3 | 2018 | 32 | 0.270 |
Why?
| | Follow-Up Studies | 5 | 2019 | 5131 | 0.260 |
Why?
| | Length of Stay | 5 | 2024 | 1215 | 0.260 |
Why?
| | Laparoscopy | 1 | 2011 | 466 | 0.260 |
Why?
| | Sinusitis | 1 | 2009 | 221 | 0.250 |
Why?
| | Statistics, Nonparametric | 3 | 2017 | 431 | 0.250 |
Why?
| | Evidence-Based Medicine | 3 | 2020 | 740 | 0.250 |
Why?
| | Office Visits | 4 | 2007 | 93 | 0.240 |
Why?
| | Treatment Outcome | 6 | 2021 | 10811 | 0.240 |
Why?
| | Social Support | 1 | 2010 | 618 | 0.240 |
Why?
| | Cost of Illness | 2 | 2018 | 308 | 0.240 |
Why?
| | Continuity of Patient Care | 2 | 2013 | 284 | 0.240 |
Why?
| | Smartphone | 1 | 2025 | 91 | 0.220 |
Why?
| | Likelihood Functions | 1 | 2024 | 144 | 0.220 |
Why?
| | Happiness | 1 | 2004 | 21 | 0.220 |
Why?
| | Survival Rate | 3 | 2019 | 1972 | 0.220 |
Why?
| | Health Services | 1 | 2005 | 107 | 0.220 |
Why?
| | Prognosis | 5 | 2019 | 4030 | 0.210 |
Why?
| | Depressive Disorder | 1 | 2007 | 379 | 0.210 |
Why?
| | Patient Selection | 1 | 2007 | 696 | 0.210 |
Why?
| | Prospective Studies | 6 | 2025 | 7604 | 0.210 |
Why?
| | Internet | 3 | 2019 | 655 | 0.210 |
Why?
| | Time-to-Treatment | 1 | 2025 | 205 | 0.210 |
Why?
| | Drug Interactions | 2 | 2015 | 410 | 0.210 |
Why?
| | Trust | 1 | 2024 | 127 | 0.200 |
Why?
| | Attitude | 2 | 2021 | 259 | 0.200 |
Why?
| | Comparative Effectiveness Research | 2 | 2015 | 152 | 0.200 |
Why?
| | Neoplasms | 1 | 2018 | 2671 | 0.200 |
Why?
| | Headache | 2 | 2013 | 147 | 0.200 |
Why?
| | Urologists | 2 | 2020 | 17 | 0.200 |
Why?
| | Cholinergic Antagonists | 1 | 2022 | 30 | 0.190 |
Why?
| | Pharmacists | 2 | 2025 | 265 | 0.190 |
Why?
| | Databases, Factual | 5 | 2017 | 1357 | 0.190 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2022 | 42 | 0.190 |
Why?
| | Information Centers | 1 | 2001 | 4 | 0.190 |
Why?
| | Mumps Vaccine | 1 | 2021 | 13 | 0.180 |
Why?
| | Sensitivity and Specificity | 4 | 2018 | 1946 | 0.180 |
Why?
| | Brain Injuries, Traumatic | 2 | 2017 | 360 | 0.180 |
Why?
| | Australia | 3 | 2018 | 315 | 0.180 |
Why?
| | Community-Institutional Relations | 2 | 2012 | 98 | 0.180 |
Why?
| | Medicare | 2 | 2018 | 773 | 0.180 |
Why?
| | Logistic Models | 5 | 2017 | 2074 | 0.180 |
Why?
| | Herpesvirus 3, Human | 2 | 2019 | 332 | 0.180 |
Why?
| | Remote Consultation | 1 | 2001 | 54 | 0.170 |
Why?
| | Alphapapillomavirus | 1 | 2021 | 39 | 0.170 |
Why?
| | Minority Groups | 2 | 2018 | 266 | 0.170 |
Why?
| | Vaccines, Inactivated | 1 | 2021 | 68 | 0.170 |
Why?
| | Anti-Vaccination Movement | 1 | 2020 | 3 | 0.170 |
Why?
| | Birth Weight | 1 | 2004 | 516 | 0.170 |
Why?
| | Behavioral Symptoms | 1 | 2020 | 42 | 0.170 |
Why?
| | Psychology | 1 | 2021 | 85 | 0.170 |
Why?
| | Vaccines, Attenuated | 1 | 2021 | 132 | 0.170 |
Why?
| | Electronic Health Records | 2 | 2019 | 1069 | 0.170 |
Why?
| | Intussusception | 2 | 2013 | 28 | 0.170 |
Why?
| | Tetanus Toxoid | 2 | 2012 | 35 | 0.170 |
Why?
| | Perception | 2 | 2017 | 359 | 0.160 |
Why?
| | Rural Health Services | 1 | 2001 | 128 | 0.160 |
Why?
| | Reproducibility of Results | 3 | 2015 | 3284 | 0.160 |
Why?
| | Machine Learning | 1 | 2025 | 493 | 0.160 |
Why?
| | Norovirus | 1 | 2020 | 26 | 0.160 |
Why?
| | Drug Administration Schedule | 1 | 2021 | 786 | 0.160 |
Why?
| | Information Services | 1 | 1999 | 49 | 0.150 |
Why?
| | Gastroenteritis | 1 | 2020 | 69 | 0.150 |
Why?
| | Outpatient Clinics, Hospital | 2 | 2011 | 82 | 0.150 |
Why?
| | Washington | 1 | 2019 | 156 | 0.150 |
Why?
| | Camping | 1 | 1998 | 5 | 0.150 |
Why?
| | Serogroup | 1 | 2018 | 44 | 0.150 |
Why?
| | Stakeholder Participation | 1 | 2019 | 78 | 0.150 |
Why?
| | Allied Health Personnel | 1 | 2018 | 46 | 0.140 |
Why?
| | Child Development | 1 | 2023 | 475 | 0.140 |
Why?
| | Hospital Mortality | 3 | 2017 | 911 | 0.140 |
Why?
| | New Zealand | 1 | 2018 | 56 | 0.140 |
Why?
| | Diphtheria | 1 | 2017 | 20 | 0.140 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 165 | 0.140 |
Why?
| | Community Pharmacy Services | 1 | 2018 | 45 | 0.140 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2018 | 74 | 0.140 |
Why?
| | Tetanus | 1 | 2017 | 25 | 0.140 |
Why?
| | Nuclear Family | 1 | 2018 | 54 | 0.140 |
Why?
| | Morbidity | 1 | 2019 | 324 | 0.140 |
Why?
| | Health Risk Behaviors | 1 | 2017 | 16 | 0.140 |
Why?
| | Patient Discharge | 4 | 2022 | 897 | 0.140 |
Why?
| | Nebulizers and Vaporizers | 1 | 2018 | 86 | 0.140 |
Why?
| | Awareness | 1 | 2018 | 103 | 0.140 |
Why?
| | Whooping Cough | 1 | 2017 | 51 | 0.140 |
Why?
| | Social Norms | 1 | 2017 | 29 | 0.140 |
Why?
| | Population Groups | 1 | 2017 | 62 | 0.140 |
Why?
| | Infant Formula | 2 | 2010 | 75 | 0.140 |
Why?
| | Croup | 1 | 2017 | 19 | 0.130 |
Why?
| | Health Care Rationing | 2 | 2007 | 59 | 0.130 |
Why?
| | Patients | 1 | 2018 | 175 | 0.130 |
Why?
| | Transplantation Immunology | 1 | 2017 | 34 | 0.130 |
Why?
| | United Kingdom | 1 | 2018 | 318 | 0.130 |
Why?
| | Curriculum | 2 | 2015 | 992 | 0.130 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 530 | 0.130 |
Why?
| | Program Evaluation | 3 | 2007 | 898 | 0.130 |
Why?
| | Health Plan Implementation | 1 | 2018 | 142 | 0.130 |
Why?
| | Professional Practice Gaps | 1 | 2016 | 15 | 0.130 |
Why?
| | Epilepsies, Myoclonic | 1 | 2017 | 51 | 0.130 |
Why?
| | Appointments and Schedules | 3 | 2019 | 89 | 0.130 |
Why?
| | Health Education | 3 | 2010 | 341 | 0.130 |
Why?
| | Kidney Transplantation | 1 | 2023 | 708 | 0.130 |
Why?
| | Infant Mortality | 1 | 1997 | 116 | 0.120 |
Why?
| | Health Resources | 1 | 2017 | 120 | 0.120 |
Why?
| | Health Status Indicators | 1 | 2016 | 171 | 0.120 |
Why?
| | Postoperative Period | 1 | 2016 | 342 | 0.120 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 73 | 0.120 |
Why?
| | Equipment and Supplies | 1 | 2015 | 42 | 0.120 |
Why?
| | Probability | 2 | 2007 | 304 | 0.120 |
Why?
| | Neurosurgical Procedures | 1 | 2017 | 197 | 0.120 |
Why?
| | Pain | 1 | 2020 | 756 | 0.120 |
Why?
| | Longitudinal Studies | 2 | 2021 | 2844 | 0.120 |
Why?
| | Multiple Organ Failure | 1 | 2015 | 128 | 0.120 |
Why?
| | Health Personnel | 2 | 2019 | 710 | 0.110 |
Why?
| | Cause of Death | 1 | 1997 | 434 | 0.110 |
Why?
| | Research Support as Topic | 1 | 2015 | 119 | 0.110 |
Why?
| | Communication Barriers | 1 | 2015 | 104 | 0.110 |
Why?
| | Insurance Claim Reporting | 1 | 2014 | 24 | 0.110 |
Why?
| | Utilization Review | 1 | 2014 | 36 | 0.110 |
Why?
| | Gastroenterology | 1 | 2016 | 180 | 0.110 |
Why?
| | Graft Survival | 1 | 2017 | 535 | 0.110 |
Why?
| | Cluster Analysis | 1 | 2015 | 499 | 0.110 |
Why?
| | Anti-Asthmatic Agents | 1 | 2018 | 395 | 0.110 |
Why?
| | Specialties, Surgical | 2 | 2012 | 75 | 0.100 |
Why?
| | ROC Curve | 1 | 2015 | 554 | 0.100 |
Why?
| | Sexual Behavior | 1 | 2018 | 485 | 0.100 |
Why?
| | Sex Factors | 1 | 2019 | 2071 | 0.100 |
Why?
| | Prevalence | 1 | 2020 | 2734 | 0.100 |
Why?
| | Home Nursing | 1 | 2013 | 25 | 0.100 |
Why?
| | Eligibility Determination | 2 | 2004 | 65 | 0.100 |
Why?
| | Statistics as Topic | 1 | 2014 | 307 | 0.100 |
Why?
| | Magnesium | 1 | 2013 | 156 | 0.100 |
Why?
| | Circovirus | 1 | 2013 | 7 | 0.100 |
Why?
| | Patient Satisfaction | 2 | 2018 | 660 | 0.100 |
Why?
| | Mentors | 1 | 2015 | 202 | 0.100 |
Why?
| | Decision Support Techniques | 1 | 2017 | 421 | 0.100 |
Why?
| | Societies, Medical | 1 | 2017 | 820 | 0.100 |
Why?
| | Graft Rejection | 1 | 2017 | 624 | 0.100 |
Why?
| | Drug Contamination | 1 | 2013 | 53 | 0.100 |
Why?
| | Interdisciplinary Communication | 1 | 2014 | 191 | 0.100 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2013 | 63 | 0.100 |
Why?
| | Inpatients | 1 | 2017 | 500 | 0.100 |
Why?
| | Recovery of Function | 1 | 2016 | 653 | 0.100 |
Why?
| | Guatemala | 3 | 2019 | 327 | 0.100 |
Why?
| | Emotions | 1 | 2017 | 548 | 0.100 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2013 | 125 | 0.100 |
Why?
| | Infant, Premature | 1 | 2016 | 574 | 0.090 |
Why?
| | Acute Disease | 2 | 2009 | 1007 | 0.090 |
Why?
| | Critical Care | 1 | 2017 | 601 | 0.090 |
Why?
| | Professional Practice Location | 1 | 2011 | 29 | 0.090 |
Why?
| | Telemedicine | 1 | 2021 | 862 | 0.090 |
Why?
| | Mothers | 2 | 2010 | 754 | 0.090 |
Why?
| | History, 20th Century | 2 | 2005 | 325 | 0.090 |
Why?
| | Mental Health | 1 | 1998 | 726 | 0.090 |
Why?
| | Factor Analysis, Statistical | 1 | 2012 | 283 | 0.090 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2031 | 0.090 |
Why?
| | Ultrasonography | 1 | 2015 | 759 | 0.090 |
Why?
| | Self Report | 1 | 2016 | 827 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1066 | 0.090 |
Why?
| | Models, Organizational | 1 | 2012 | 151 | 0.090 |
Why?
| | Pharmaceutical Services | 1 | 2011 | 83 | 0.090 |
Why?
| | Income | 1 | 2012 | 202 | 0.090 |
Why?
| | Patient Care Team | 2 | 2025 | 631 | 0.090 |
Why?
| | Organizations, Nonprofit | 1 | 2010 | 17 | 0.090 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2015 | 293 | 0.090 |
Why?
| | Schools | 1 | 2014 | 461 | 0.080 |
Why?
| | Altitude | 1 | 2015 | 488 | 0.080 |
Why?
| | Fees, Pharmaceutical | 1 | 2010 | 9 | 0.080 |
Why?
| | Hospitals, Teaching | 1 | 2011 | 118 | 0.080 |
Why?
| | Community-Based Participatory Research | 1 | 2012 | 162 | 0.080 |
Why?
| | Swine | 1 | 2013 | 775 | 0.080 |
Why?
| | Drug Utilization | 1 | 2011 | 169 | 0.080 |
Why?
| | Cognition | 1 | 2018 | 1153 | 0.080 |
Why?
| | Drug Overdose | 1 | 2014 | 347 | 0.080 |
Why?
| | Odds Ratio | 1 | 2012 | 1070 | 0.080 |
Why?
| | Job Satisfaction | 1 | 2011 | 218 | 0.080 |
Why?
| | Health Expenditures | 1 | 2010 | 189 | 0.080 |
Why?
| | Pain Measurement | 1 | 2011 | 521 | 0.070 |
Why?
| | Socioeconomic Factors | 3 | 2018 | 1289 | 0.070 |
Why?
| | Cystic Fibrosis | 1 | 2018 | 1114 | 0.070 |
Why?
| | Down Syndrome | 1 | 2015 | 496 | 0.070 |
Why?
| | Nephrology | 1 | 2009 | 61 | 0.070 |
Why?
| | Epidemiologic Research Design | 1 | 2008 | 29 | 0.070 |
Why?
| | Efficiency, Organizational | 1 | 2008 | 140 | 0.070 |
Why?
| | Cell Phone | 2 | 2019 | 76 | 0.070 |
Why?
| | Demography | 1 | 2008 | 291 | 0.070 |
Why?
| | Disease Management | 2 | 2017 | 628 | 0.070 |
Why?
| | Accident Prevention | 1 | 2006 | 26 | 0.060 |
Why?
| | Diagnosis-Related Groups | 1 | 2006 | 31 | 0.060 |
Why?
| | Emigrants and Immigrants | 1 | 2009 | 136 | 0.060 |
Why?
| | Health Maintenance Organizations | 1 | 2006 | 108 | 0.060 |
Why?
| | Risk-Taking | 1 | 2009 | 348 | 0.060 |
Why?
| | Bottle Feeding | 1 | 2006 | 21 | 0.060 |
Why?
| | Drug Industry | 1 | 2007 | 111 | 0.060 |
Why?
| | Infant Care | 1 | 2006 | 45 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 816 | 0.060 |
Why?
| | Caregivers | 1 | 2013 | 877 | 0.060 |
Why?
| | Surgical Procedures, Operative | 1 | 2008 | 259 | 0.060 |
Why?
| | France | 1 | 2005 | 33 | 0.060 |
Why?
| | Urban Health | 1 | 2005 | 92 | 0.060 |
Why?
| | Rural Health | 1 | 2005 | 80 | 0.060 |
Why?
| | Weight Loss | 1 | 2010 | 787 | 0.060 |
Why?
| | Mass Media | 1 | 2005 | 42 | 0.060 |
Why?
| | Early Detection of Cancer | 1 | 2009 | 447 | 0.060 |
Why?
| | Pilot Projects | 2 | 2025 | 1710 | 0.060 |
Why?
| | Office Automation | 1 | 2004 | 6 | 0.050 |
Why?
| | Administration, Intravenous | 1 | 2024 | 155 | 0.050 |
Why?
| | Policy Making | 1 | 2004 | 98 | 0.050 |
Why?
| | Philadelphia | 1 | 2003 | 49 | 0.050 |
Why?
| | Professional Role | 1 | 2025 | 167 | 0.050 |
Why?
| | Medical Indigency | 1 | 2003 | 11 | 0.050 |
Why?
| | Counseling | 1 | 2006 | 391 | 0.050 |
Why?
| | Florida | 1 | 2003 | 107 | 0.050 |
Why?
| | Ohio | 1 | 2003 | 152 | 0.050 |
Why?
| | Kidney Failure, Chronic | 1 | 2009 | 570 | 0.050 |
Why?
| | Play and Playthings | 1 | 2023 | 33 | 0.050 |
Why?
| | International Classification of Diseases | 1 | 2004 | 135 | 0.050 |
Why?
| | Propensity Score | 1 | 2024 | 294 | 0.050 |
Why?
| | Poverty Areas | 1 | 2002 | 39 | 0.050 |
Why?
| | Language Development | 1 | 2023 | 61 | 0.050 |
Why?
| | Hospitalists | 1 | 2007 | 245 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2011 | 7635 | 0.050 |
Why?
| | Administration, Oral | 1 | 2024 | 816 | 0.050 |
Why?
| | Interprofessional Relations | 1 | 2004 | 283 | 0.050 |
Why?
| | Regional Medical Programs | 1 | 2001 | 7 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2009 | 806 | 0.050 |
Why?
| | Education, Medical | 1 | 2005 | 266 | 0.050 |
Why?
| | Linear Models | 1 | 2004 | 849 | 0.050 |
Why?
| | Fever | 1 | 2022 | 306 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 208 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 2892 | 0.040 |
Why?
| | Hospitals, Rural | 1 | 2000 | 39 | 0.040 |
Why?
| | Living Donors | 1 | 2023 | 295 | 0.040 |
Why?
| | Private Sector | 1 | 2000 | 52 | 0.040 |
Why?
| | Language | 1 | 2023 | 292 | 0.040 |
Why?
| | Evaluation Studies as Topic | 1 | 2000 | 180 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 129 | 0.040 |
Why?
| | Wounds and Injuries | 1 | 2006 | 758 | 0.040 |
Why?
| | Medication Adherence | 1 | 2023 | 467 | 0.040 |
Why?
| | Databases as Topic | 1 | 1999 | 67 | 0.040 |
Why?
| | Maternal Age | 1 | 2019 | 129 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2007 | 3556 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 347 | 0.040 |
Why?
| | Eggs | 1 | 1998 | 25 | 0.040 |
Why?
| | Nursing Assessment | 1 | 1998 | 59 | 0.040 |
Why?
| | Nursing Staff, Hospital | 1 | 2000 | 162 | 0.040 |
Why?
| | Health Status | 1 | 2003 | 792 | 0.030 |
Why?
| | Health Behavior | 1 | 2023 | 762 | 0.030 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 1 | 2017 | 17 | 0.030 |
Why?
| | Nurse-Patient Relations | 1 | 1998 | 70 | 0.030 |
Why?
| | Veins | 1 | 2017 | 63 | 0.030 |
Why?
| | Educational Status | 1 | 2019 | 470 | 0.030 |
Why?
| | Obesity | 1 | 2010 | 2992 | 0.030 |
Why?
| | Social Class | 1 | 1999 | 282 | 0.030 |
Why?
| | Neonatal Screening | 1 | 2018 | 169 | 0.030 |
Why?
| | Drug Hypersensitivity | 1 | 1998 | 90 | 0.030 |
Why?
| | Palivizumab | 1 | 2016 | 13 | 0.030 |
Why?
| | Glasgow Coma Scale | 1 | 2017 | 186 | 0.030 |
Why?
| | Liver Failure | 1 | 2016 | 94 | 0.030 |
Why?
| | Organ Dysfunction Scores | 1 | 2015 | 48 | 0.030 |
Why?
| | Arteries | 1 | 2017 | 269 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1316 | 0.030 |
Why?
| | Food Hypersensitivity | 1 | 1998 | 183 | 0.030 |
Why?
| | Canada | 1 | 2016 | 418 | 0.030 |
Why?
| | Hypotension | 1 | 2015 | 122 | 0.030 |
Why?
| | Direct Service Costs | 1 | 2014 | 9 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2013 | 206 | 0.030 |
Why?
| | Community Mental Health Services | 1 | 2013 | 84 | 0.030 |
Why?
| | Risk | 1 | 2015 | 912 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1622 | 0.020 |
Why?
| | Migraine Disorders | 1 | 2013 | 102 | 0.020 |
Why?
| | Accreditation | 1 | 2012 | 83 | 0.020 |
Why?
| | Certification | 1 | 2012 | 113 | 0.020 |
Why?
| | Sleep | 1 | 2017 | 755 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2757 | 0.020 |
Why?
| | Animals | 1 | 2013 | 36940 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3196 | 0.020 |
Why?
| | Healthy People Programs | 1 | 2007 | 8 | 0.020 |
Why?
| | Education, Medical, Graduate | 1 | 2012 | 486 | 0.020 |
Why?
| | Domestic Violence | 1 | 2006 | 53 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 3958 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2008 | 307 | 0.010 |
Why?
| | Renal Dialysis | 1 | 2009 | 435 | 0.010 |
Why?
| | Postoperative Care | 1 | 2007 | 261 | 0.010 |
Why?
| | Survival Analysis | 1 | 2008 | 1325 | 0.010 |
Why?
| | Cost Control | 1 | 2004 | 39 | 0.010 |
Why?
| | Orthopedics | 1 | 2007 | 144 | 0.010 |
Why?
| | Preoperative Care | 1 | 2007 | 362 | 0.010 |
Why?
| | Directly Observed Therapy | 1 | 2004 | 16 | 0.010 |
Why?
| | Biomarkers | 1 | 2015 | 4149 | 0.010 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2006 | 261 | 0.010 |
Why?
| | Internship and Residency | 1 | 2013 | 1147 | 0.010 |
Why?
| | Schools, Medical | 1 | 2004 | 147 | 0.010 |
Why?
| | Patient Care | 1 | 2004 | 111 | 0.010 |
Why?
| | Hospital Records | 1 | 2000 | 12 | 0.010 |
Why?
| | Research | 1 | 2004 | 451 | 0.010 |
Why?
| | Contraindications | 1 | 1998 | 90 | 0.010 |
Why?
|
|
Kempe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|